PillRx only · Injection, Solution · Endotracheal
Atropine Sulfate
Atropine Sulfate
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
372
Rx · 2026 Q1
434
Units dispensed
+9%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| Henry Schein Inc. | unknown | 2 | SUPPLYING |
| Accord Healthcare Inc. | unknown | 1 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 1 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 3, 2023RECALLRecall (Class II): Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only, Manufactured for: …
Presence of Particulate Matter: Particulate matter identified as fiber. — Recalling firm: Accord Healthcare, Inc. — Nationwide within the United States
- Jan 1, 2012SHORTAGEDrug shortage: Atropine Sulfate Injection (Fresenius Kabi USA, LLC)
Atropine Sulfate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anesthesia, Neurology, Pediatric.